EUVIMEDEUVIMED entdecken
Crossref

A Slowly Self‐Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties

Duyen Thi My Ho, Kohei Yamada iD, Hideyuki Sato iD, Satomi Onoue iD

Biopharmaceutics & Drug Disposition · 23.05.2026

DOI: 10.1002/bdd.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, online erschienen am 23.05.2026. Verfasst von Duyen Thi My Ho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study is the first attempt to develop a novel slowly self‐emulsifying drug delivery system (SL‐SEDDS) of sesamin (SES) for improved biopharmaceutical properties. Firstly, SES‐loaded self‐emulsifying drug delivery system (SEDDS/SES) comprising krill oil, medium‐chain triglyceride, Tween 80, and propylene glycol with 1.5 w/w% SES loading was prepared and optimized using a pseudo‐ternary phase diagram. Then, SES‐loaded SL‐SEDDS (SL‐SEDDS/SES) was produced by mixing the optimized SEDDS/SES with varying Geleol (solid lipid) contents. The resulting formulations were evaluated in terms of their physicochemical properties and pharmacokinetics. The self‐emulsifying potency of SL‐SEDDS/SES remained largely unaffected by the presence of Geleol. The dissolution behavior of SES in SL‐SEDDS/SES improved relative to that of crystalline SES, with sustained release that was dependent on Geleol content. Notably, SL‐SEDDS/SES containing 20 w/w% Geleol content (SL‐SEDDS/SES‐20) performed favorable sustained release with 65% dissolved SES at 6 h. After oral administration of SES samples (20 mg‐SES/kg) in rats, SL‐SEDDS/SES‐20 showed 7.9‐fold higher area under the curve of plasma concentration‐time profile than that of crystalline SES. Additionally, it reduced the peak systemic exposure observed with SEDDS/SES, with a 22% lower C max and a prolonged mean residence time (MRT) of 5.3 h. These findings suggest that SL‐SEDDS is a promising dosage form for enhancing the biopharmaceutical properties of SES and potentially other lipophilic nutraceuticals.

Schlagwörter

Stichwörter der Autor:innen

oral absorptionoral bioavailabilitysesaminslowly self‐emulsifying drug delivery systemsustained release

Autor:innen und Institutionen

  • Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.

ORCID-Profile: Kohei Yamada, Hideyuki Sato, Satomi Onoue

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ho, D. T. M., Yamada, K., Sato, H., & Onoue, S. (2026). A Slowly Self‐Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70033

Vancouver

Ho DTM, Yamada K, Sato H, Onoue S. A Slowly Self‐Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties. Biopharmaceutics & Drug Disposition. 2026. doi:10.1002/bdd.70033

BibTeX
@article{Ho2026,
  author = {Ho, Duyen Thi My and Yamada, Kohei and Sato, Hideyuki and Onoue, Satomi},
  title = {A Slowly Self‐Emulsifying Delivery System of Sesamin With Improved Biopharmaceutical Properties},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2026},
  doi = {10.1002/bdd.70033}
}
Kostenlos starten →